PRESENTATION
H1 FY2022 — Results presentation
H1 FY2022PDF · 72 pages6.5 MB
UNAUDITED INTERIM RESULTS for the six months ended 31 December 2021 -- 1 of 72 -- 2 +2% new business API, including DH take- on of new closed schemes and gross revenue for Vitality Group Core new business +6% to R10 475m Normalised operating profit +8% to R4 872m Normalised headline earnings +26% to R2 876m Headline earnings +78% to R3 278m GLOBAL -- 2 of 72 -- 3 USA Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Vitality Car Vitality Life Vitality Invest Vitality Health HEALTH -- 3 of 72 -- 4 Three concurrent areas of focus Navigating COVID-19 Drive for growth Robust performance with capital and liquidity strength -- 4 of 72 -- Navigating COVID-19 -- 5 of 72 -- 6 Most severe COVID-19 claims in period, but fourth wave was less severe than previous waves D614G Beta Delta Omicron R538m Discovery Life COVID claims R3 940m Discovery Life COVID claims R1 871m Discovery Life COVID claims R115m Discovery Life COVID claims H1 2021 H1 2022 R698m R3 366m R2 344m Discovery Life Gross COVID claims Discovery Life Gross COVID claims Discovery Life Gross COVID claims H2 2021 R55m Discovery Life Gross COVID claims H2 2020 Excess deaths Individual Life provisions remain intact, expected to be sufficient for H2 22 claims 80% IFRS provision utilisation in H1 22 2,303 1,838 465 Provision at 30 June 2021 Utilisation Remaining Provision at 31 December 2021 -- 6 of 72 -- 7 12,584 19,042 19,956 23,437 0 500 1000 1500 2000 2500 3000 3500 0 4000 8000 12000 16000 20000 24000 05-Mar 25-Apr 14-Jun 03-Aug 22-Sep 11-Nov 31-Dec 19-Feb 10-Apr 30-May 19-Jul 07-Sep 27-Oct 16-Dec 04-Feb 7-day moving average of daily admissions and deaths 7-day moving average of daily cases Hospital Admissions Reported Cases 178 days 7-day moving average of new COVID-19 cases and hospital admissions 172 93 Recurring pattern in the 4 South African COVID-19 waves to date days between peaks on average days average length of wave incl Delta (80 excl Delta) Source of hospital admissions data: Lucille Blumberg, Richard Welch and Waasila Jassat – DATCOV, NICD D614G Beta Delta Omicron 176 days 162 days 0% 2% 4% 6% 8% 10% 12% Apr-20 Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 Discovery Health clients case fatality rate reducing over time 14 Day Average Case Fatality Rate: 1 April 2020-31 December 2021 Deaths as % of confirmed infections -- 7 of 72 -- 8 COVID-19 mutates in parallel – next variant hasn’t come from the last Flu Measles Mutates a lot to escape our immunity. One major lineage, and every few years, a new variant sweeps and the others go extinct Virus mutates in a ladder- like pattern, so fairly predictable Does not mutate to escape immunity, more balanced evolutionary tree No immune pressure that pushes one mutation to outcompete another Mutations haven’t evolved in a ladder-like fashion - the next variant hasn’t been coming from the last COVID-19 Time Time Selection SOURCE: https://yourlocalepidemiologist.substack.com/p/predicting-the-next-booster No selection -- 8 of 72 -- 9 Source: Centers of Disease Control and Prevention https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e2.htm Vaccination is important Unvaccinated Pfizer 2-dose Pfizer 3-dose 70% 90% Unvaccinated Pfizer 2-dose Pfizer 3-dose 92% 99% Source: MedRxiv https://ncrc.jhsph.edu/ Source: Discovery Health Analytics as at 19 February 2022 To be submitted for peer review and publication. Authors have no conflicts of interest direct or in kind Lower mortality risk Lower hospitalisation risk Lower transmission risk Every 20% increase in vaccination leads to 50% reduction in positive tests for unvaccinated people Vaccine effectiveness was retained through Omicron Vaccines remain highly effective at reducing mortality * Includes all COVID-19 claims since the start of the pandemic Unvaccinated / Unknown Partially Vaccinated Fully Vaccinated Historic Life COVID-19 claims* by vaccination status: Relative risk of severe illness (Dec-Jan) Risk of infection Deaths per 100,000 between Oct-Nov Exposed to unvaccinated Exposed to vaccinated 79% -- 9 of 72 -- 10 SA population has strong and increasing levels of immunity Boosters and vaccination are essential, even after infection 70%-80% of population have immunity, but it wanes due to reinfection risk* *Reinfection rate of 20% for all waves except 55% for the Omicron wave. Actual COVID-19 deaths and the Verity IFR to determine the number of infections 0% 20% 40% 60% 80% 100% 20200201 20200222 20200314 20200404 20200425 20200516 20200606 20200627 20200718 20200808 20200829 20200919 20201010 20201031 20201121 20201212 20210102 20210123 20210213 20210306 20210327 20210417 20210508 20210529 20210619 20210710 20210731 20210821 20210911 20211002 20211023 20211113 20211204 20211225 20220115 % Infected 0% 20% 40% 60% 80% 100% 20200201 20200222 20200314 20200404 20200425 20200516 20200606 20200627 20200718 20200808 20200829 20200919 20201010 20201031 20201121 20201212 20210102 20210123 20210213 20210306 20210327 20210417 20210508 20210529 20210619 20210710 20210731 20210821 20210911 20211002 20211023 20211113 20211204 20211225 20220115 % Infected % Vaccinated % Vulnerable c18% population vulnerable, but can increase given immunity is not durable Immunity from prior infection -- 10 of 72 -- 11 Encouraging COVID-19 trends, provisions remain intact to cover best estimate scenario At least partially vaccinated Fully vaccinated over age 60 Total lives Members over age 60 Health 49% 81% 72% Individual Life* 75% 82% 75% Group Life* 78% 88% 82% Higher risk Discovery population vaccinated Actual % vaccinated *Sum assured weighted Individual Life provisions remain intact, expected to be sufficient for H2 22 claims 80% IFRS provision utilisation in H1 22 2,303 1,838 465 Provision at 30 June 2021 Utilisation Remaining Provision at 31 December 2021 Case fatality rates reduced significantly 1 3 5 7 9 11 13 15 17 19 21 23 25 27 Weeks 1st Wave 2nd Wave 3rd Wave 4th Wave Life deaths -- 11 of 72 -- Financial results -- 12 of 72 -- 13 Health 1 750 +5% 3 598 +29% Life 1 934 +1% 1 267 +9% Invest 517 +10% 1 519 +15% Insure 15 -86% 597 -3% Vitality Health 850 +39% 708 +11% Vitality Life 361 +10% 554 -1% Vitality Group 234 -2% 668 +7% Ping An Health 140 +25% 1 426 -21% Bank (498) -18% >200k New-to-Bank clients +151% Other New (470) +21% 772 -23% +6% Core new business API R10.5bn +8% Operating profit R4.9bn Resilient performance Resilient financial performance, supported by continued operational efficiency and new business over the period Strong positive experience variances with robust capital and liquidity positions. R6bn gross COVID-19 claims paid cumulatively, reduced asset base returns impacting earnings Robust performance with strong increase in new business growth and assets under management Difficult period, characterised by an increased loss ratio driven by adverse weather events combined with motor parts inflation dramatically exceeding CPI Excellent operating performance driven by sustained membership growth, rigorous expense controls and excellent care management Robust performance as a result of management actions taken over previous reporting periods. Made significant progress with Prudential in agreeing the terms of a long-term deferral of the Part VII transfer Strong underlying growth, with growth in profit from operations impacted by foreign exchange gains in the prior period not being repeated Robust profit growth. New business written premium reduced due to rebasing co- operation with Ping An Life for business written in certain regions in China Operating loss reducing faster than plan due to excellent performance across all metrics. Benefits of the business model continue to manifest in improving operating leverage 8% of Group operating profit on new (excl bank) vs 7% in the prior period. Half of spend relates to Vitality Group with a notable increase in globalising Discovery’s Vitality and Health capabilities via Vitality Health International ZARm -- 13 of 72 -- 14 - 1,000 2,000 3,000 4,000 5,000 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Maintaining excellent growth Operating profit (Rm) +8% Core new business (Rm) - 2,000 4,000 6,000 8,000 10,000 12,000 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +6% -- 14 of 72 -- 15 Businesses better off than pre-COVID-19 Life insurance Health insurance H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R1 750m +5% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R1 934m +1% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +10% to R517m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R15m -86% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to £41.5m +44% +25% to R140m +7% to $15.5m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to £17.6m +15% to R1 267m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +9% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R3 598m +29% Excl new closed schemes H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +15% to R1 519m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R597m -3% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +15% to £34.5m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +3% to £27.1m +16% to $44.5m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 -21% to R5.7bn* H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Operating profit New business H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 *100% PAH H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 -- 15 of 72 -- 16 - 1,000 2,000 3,000 4,000 5,000 6,000 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 - 50 100 150 200 250 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Investing heavily offshore, strong operating profit in the strands 16% 18% 18% 8% 52% 42% 52% 41% % in New x% Operating profit (ZARm): 4% 47% -11% +135% +36% - 200 400 600 800 1,000 1,200 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 - 1,000 2,000 3,000 4,000 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +4% +5% +2% -5% +72% 8% 9% 33% 31% 17% +30% +110% -21% +0% 71% Bank and Vitality Group Bank Other SA UK VG 51% 18% 11% 20% 17% 18% 21% 13% 6% +8% +19% +0% -4% Total Group: -- 16 of 72 -- 17 21% 22% 23% 24% 25% 26% 27% 28% 29% FY 2020 H1 2021 FY 2021 H1 2022 Group is well capitalised and highly liquid Dec 20 Cover Dec 21 Cover Life 1.8x 1.8x Insure 1.8x 1.8x VH 2.0x 1.9x VL 2.0x 2.2x Bank1 1.3x 1.4x PAH2 2.1x 2.1x 1 Capital Adequacy Ratio 2 Before capital injection 3 Considers SA Liquidity and liquid excess assets for Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank 4 SA cash + undrawn committed facilities SA Liquidity4 , R millions FLR R millions Liquid excess assets above minimum regulatory capital requirements Strongly capitalised FLR is within target Highly liquid across the Group3 Sufficient liquidity at the centre DHMS solvency (unaudited) 38.6% 23.9% - 4 000 8 000 12 000 16 000 FY 2020 H1 2021 FY 2021 H1 2022 - 500 1 000 1 500 2 000 2 500 FY 2020 H1 2021 FY 2021 H1 2022 28% -- 17 of 72 -- 18 Annualised ROEV 14% excluding COVID-19, forex and economic changes Opening EV Value of new business Unwind of discount rate Non-economic experience variances and methodology & assumption changes Operational EV Economic experience variances and methodology & assumption changes Forex Finance costs Other Change in capital and dividends Closing EV +22.7% Group Embedded Value R82 920m R80 895m R74 645m Operational EV Economic and other +17% Annualised ROEV -- 18 of 72 -- 19 Reported profit for period affected by three key factors Rm 6 months ended Dec 2021 6 months ended Dec 2020 % Normalised profit from operations 4,872 4,507 +8% Economic assumptions adjustment - DL 498 -493 Economic assumptions adjustment - VL -46 1 Finance charges excl. 1DP finance lease -698 -649 Unrealised gains/(losses) on foreign exchange contracts not designated as a hedge 99 -207 Foreign exchange gains/(losses) 128 -362 Deferral fees related to Prudential Book transfer -92 -96 Investment income and fair value remeasurements 134 149 Vaccination costs -137 - Other -49 -231 Profit before tax 4,709 2,619 +80% Tax -1,404 -744 Profit attributable to preference shareholders -28 -34 Profit attributable to equity holders 3,277 1,841 +78% Headline adjusting items 1 1 Headline earnings 3,278 1,842 +78% Economic assumptions adjustment (DL and VL) -321 354 Other normalisation adjustments -81 88 Normalised headline earnings 2,876 2,284 +26% 1 2 3 1 2 3 In SA, significant drop in real interest rates In UK, derivatives highly effective in mitigating volatility, convexity costs of GBP2.2m Extreme volatility in Rand with significant weakening of the Rand compared to a strengthening in the prior period Continued investment in supporting the national vaccination campaign in SA Due to the continued uncertainty caused by COVID-19 on the demographic and economic environment in SA, the Discovery Board has decided to retain its prior stated position during the pandemic and has decided not to declare an ordinary interim dividend for the period ended 31 December 2021. The reintroduction of an ordinary interim dividend will be considered on an ongoing basis -- 19 of 72 -- The Vitality shared-value model -- 20 of 72 -- 21 The three trends remain relevant NATURE OF RISK TECHNOLOGY SOCIAL RESPONSIBILITY Standard risk factors, behavioural risk factors, correlations, pricing precision Digital functionality, engagement, behaviour change, personalisation Make people healthier, good for society, good for the planet HEALTH MONEY DRIVE -- 21 of 72 -- 22 Conviction in the model PREDICTION TECHNOLOGY ENGAGEMENT AND INTERVENTION HEALTH INSURANCE TECHNOLOGY AND INTELLIGENCE PRODUCT DATA Know Your Health Improve Your Health Get Rewarded> > Healthy Futures State of the art health assessment framework Assessment Healthspan calculation engine GateWay Connectivity enabler connecting devices, wellness and health providers and rewards Vitality Data Exchange Vitality Data Portal SDK Partner Classification Adherence API Next Best Action Next Best Action Leading health recommendation engine Lifestyle Goals Promotions Notifications Quizzes Content Manager Signature Experiences Vitality Points Vitality Status Incentives and rewards Prediction Engagement Shared-value -- 22 of 72 -- 23 Risk prediction with Healthy Futures -- 23 of 72 -- 24 Example -- 24 of 72 -- 25 Next Best Action MEMBER DATA HEALTHSPAN CASUAL INFERENCE Demographics Engagement history Health claims Life claims Preferences ∆qx │ ∆behaviour Quit smoking Lose weight Manage stress & burn-out Become active Increase level of physical activity Quit smoking experience 12 weeks Healthy weight experience 12 weeks Be well experience 6 weeks Get active experience 6 weeks Weekly Coaches Coaches “Try this activity next week” +10 points PREDICT RECOMMEND INCENTIVISE Cycle is repeated -- 25 of 72 -- Execution in the three strategic strands -- 26 of 72 -- 27 1 2 3 The strategic strands Perfect composite model, #1 in every industry, and the Bank pivoting to growth as the composite-maker within SA Best-in-breed products across businesses and operating as a fully integrated composite business with a seamless One Vitality client journey. A successful entry into motor insurance Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our Vitality shared-value and health management capabilities to assist them in making their customers healthier, while ensuring their products are more competitive with better margins Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Vitality Health Vitality Car Vitality Life Vitality Invest USA HEALTH -- 27 of 72 -- 28 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Excellent performance across all metrics, performance exceeded expectations resulting in the Bank’s operating loss reducing faster than plan -- 28 of 72 -- 29 Key focus areas for the Bank Full service bank at scale Shared-value banking model Vitality Money Digital Bank scalability 1 2 3 Transaction and credit cards Demand, tax-free, notice & fixed-deposit accounts (24hr – 5 years) Multi-currency accounts Vitality Money Financial Analyser 5 key financial behaviours Dynamic interest rates Dynamic, deep discounts Shared-value rewards currency 4.4% 8.5% Savings Lending Virtual cards Electronic KYC Live Assist Mobile Web Virtual cards Electronic KYC Live Assist Mobile Web <5min onboarding Operating leverage 24/7/365 availability Strong returns 2021 2022 2023 2024 2025 2026 Base Upside Current Market-leading app functionality -- 29 of 72 -- 30 Discovery Bank’s key performance metrics trending positively Total clients Total accounts Retail deposits Advances Operating result >400k >850k R9.5bn R4.2bn -R498m Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Bin - Not Upgraded Bin - Upgraded New to Bank Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Headline figures as at February 2022 H1 FY18* H1 FY19* H1 FY20 H1 FY21 H1 FY22 *Includes capital development costs during build phase -- 30 of 72 -- 31 Growth of 750+ high quality clients per day New business composition Average daily new business Channel mix Product mix ~750 average daily sales; highest new business levels across the SA Composite 0 100 200 300 400 500 600 700 800 Life (Excluding standalone products)* Invest* Insure* Health (Individual)* Bank * Average daily new business from July 2021 to Jan 2022 Healthy distribution of “Discovery” and “new-to-Discovery” clients 30% 14% 7% 3% 46% 1 Product 2 Products 3 Products 4+ Products New to Discovery 0% 20% 40% 60% 80% 100% Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Self-assisted Connect Intermediated Diversified channels – traction in intermediated channel 0% 20% 40% 60% 80% 100% Dec '20 Dec '21 Savings only Trans PAYT Trans Bundle Credit & Suite ±50% Credit and Transaction Bundled sales -- 31 of 72 -- 32 Market-leading NIR per client with strong engagement Engagement mix Gross NIR pcpm (DSY v market) Spend 31% Growth in spend y-o-y 34% Primary and highly active clients 34% 47% 20% Primary and highly active Active Inactive • Primary and highly active – ≥15% of net income as spend – for primary clients, salary deposits/ equivalent inflow • Active – <15% of net income as spend • Inactive – No activity or not in good standing DSY >12m Bank 1 Bank 2 DSY Big 4 average (excl DSY) Bank 3 DSY <12m Bank 4 16% Higher than Big 4 average +16% -- 32 of 72 -- 33 Increasing market share of high-quality advances book Credit card market share Average advances Credit loss ratio Net interest margin Total NII 0% 4% 8% 12% 16% 20% DSY market share 2021 DSY market share Oct -Nov ±20% Market share in >R100k pm income band #1 Card volume in high-net-worth segment* *Signature and Infinite VISA card volume R4.2bn Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 J 0% 1% 2% 3% 4% 5% 6% 7% 8% Q1 FY1 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 J 80% 90% 100% 110% Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 J Cost of funds Net interest margin Indexed to Q2 FY21; Q1 FY21 excluded due to billing anomalies during the BIN migrations Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Indexed to Q2 FY21 -- 33 of 72 -- 34 Shared-value model correlations driving positive client and financial outcomes 4.4% * Bronze lapse rate higher than Blue as these clients had some engagement and so are more willing to phone the call centre to close their account vs leaving account idle Funding 1 2 11 64 Blue Bronze Silver Gold and Diamond Average deposits 7x higher average deposit Gold and Diamond vs Book average Revenue 1.0 1.7 2.6 4.0 Blue Bronze Silver Gold and Diamond Spend 4x higher spend Gold and Diamond vs Blue Indexed to Blue Indexed to Blue Advances 100% Blue Bronze Silver Gold and Diamond Arrears rate by VM status 96% lower arrears rate Gold and Diamond vs Blue Vitality Money correlations transcend income bands 100% Gold Platinum Black Purple Arrears rate by product colour -- 34 of 72 -- 35 Digital scalability driving 40% positive operating leverage Revenue vs expense growth indexed to Jan 21 50% 60% 70% 80% 90% 100% 110% 120% Gross NIR pcpm Expenses per account * As at Feb 2022; Other banks include FNB, ABSA, Nedbank and Standard Bank Revenue per client Expenses per client Expenses Clients H1 FY21 H1 FY22 +2.5% +35% Spend/client Fees/client H1 FY21 H1 FY22 +9% +2% 40% -- 35 of 72 -- 36 Discovery Bank tracking ahead of upside scenarios to deliver attractive returns and profitability 2021 2022 2023 2024 2025 2026 Base Upside Current Business case sensitivities and scenarios • In addition to the above assumptions, the financials are sensitive to other factors such as the CLR, marketing spend, advances trajectory, deposits trajectory, cost of funds, regulatory capital requirements, inflation etc. • These sensitivities illustrates the pattern of profit emergence to breakeven and are not intended to be a forecast. Forward looking information on this slide is for illustration purposes and has not been reviewed or reported on by the auditors Key financial levers Average advances pc (Rands) Average gross NIR pcpm (growth; %, before rewards and expenses, long-term assumptions represent a CAGR between FY22 and FY26) Expenses growth (%, excl. depreciation/ amortization, Long-term assumptions represent a CAGR between FY22 and FY26) Model efficacy: CLR (%) Growth: clients (average daily new business) 0% 5% 10% Current Base Upside 5 10 15 Current Base Upside 0% 2% 4% Current Base Upside 0% 4% 8% 12% Current Base Upside 0 500 1,000 Current Base Upside Long-term economics (FY26) -- 36 of 72 -- 37 Key focus areas for the Bank Full service bank at scale Shared-value banking model Vitality Money Digital Bank scalability 1 2 3 Transaction and credit cards Demand, tax-free, notice & fixed-deposit accounts (24hr – 5 years) Multi-currency accounts Vitality Money Financial Analyser 5 key financial behaviours Dynamic interest rates Dynamic, deep discounts Shared-value rewards currency 4.… 8.… Savings Lending Virtual cards Electronic KYC Live Assist Mobile Web Virtual cards Electronic KYC Live Assist Mobile Web <5min onboarding Operating leverage 24/7/365 availability Strong returns 2021 2022 2023 2024 2025 2026 Base Upside Current Market-leading app functionality Composite maker 4 … -- 37 of 72 -- 38 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Performed robustly across all metrics with strong new business growth -- 38 of 72 -- 39 Discovery Health H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Normalised operating profit New business Membership Excluding the take-on of new closed schemes 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 DHMS Restricted Schemes Non Scheme Products H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R1 750m to R3 598m +5% +29% lives under administration >3.7m -- 39 of 72 -- 40 0% 2% 4% 6% 8% 10% 12% 2013 2014 2015 2016 2017 2018 2019 2020 2021 Lapse rates 5.1% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% H1 2013 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 No movements Upgrades Downgrades Discovery Health Medical Scheme performance summary Membership and growth Plan stability and low lapses Security and surplus 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 Plan movements lives >2.78m market share 57.5% credit rating AAA unaudited solvency 38.6% 0.45% increase following strong new business in a contracting market Stable and resilient membership base that is inelastic to economic shifts and changes in the healthcare environment unaudited reserves R30.8bn - 5 10 15 20 25 30 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 R billion -- 40 of 72 -- 41 0% 50% 100% 150% 200% 250% 2019 2021 Continued excellence in the closed scheme market 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 18 700k 32%closed scheme market share closed schemes lives Robust growth Consistent, stable performance across all closed schemes 25% Solvency requirement 450% 500% 0% 2% 4% 6% 8% 10% 12% 2019 2021 Average medical inflation Solvency Contribution increases -- 41 of 72 -- 42 Jan-20 Apr-20 Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 In Hospital Utilisation Out of Hospital Utilisation - Risk 13% 11% 10% 2% 11% 9% 10% 12% Cardio Musc-ske Tumours Infections 2019 2021 Key healthcare insights emerging in 2022 Healthcare utilisation is increasing following drop Population health has worsened COVID-19 has increased overall disease burden COVID-19 will continue to feature prominently COVID-19 expected to add R7bn to overall expenditure in 2022, in line with 2021 3.6% 1.6% 1.2% 1.5% 5.0% 1.8% 1.5% 5.0% Diabetes HIV Cancer Mental Health Pre-COVID-19 During COVID-19 Percentage of lives with key health issues Percentage of claims attributed to selected key healthcare drivers Hospital admissions Vaccines PCR Testing Current Cost Future Expected Cost +10% + R1 440m – R1 027 m – R462m 2019 level High utilisation end of 21 indicative of what to expect in 22 2020 2021 COVID-19 showing initial signs of impacting overall morbidity 1.5x higher risk of developing Diabetes post COVID 2.75x higher risk of developing a cardiac condition post COVID -- 42 of 72 -- 43 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Strong positive experience variances with robust capital and liquidity positions. R6bn gross COVID-19 claims paid cumulatively which reduced asset base returns and impacting earnings -- 43 of 72 -- 44 Discovery Life Record high claims paid, 3rd and 4th COVID-19 waves in this period Normalised operating profit Strong capital and liquidity New business API 184% H1 2022 3,403 H1 2022 125% SCR target 1xILT SCR coverage Liquidity coverage to R1 267m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 +9% Positive cashflow from existing book impacted by in period COVID-19 claims 698 2,344 3,366 6,408 H1 2021 H2 2021 H1 2022 Total Gross claims (Rm) Excess cash payments towards COVID-19 claims impacts on the NRR unwind, reducing earnings by cR261m (13%) in the HY period -29 2,126 640 1.42x Liquidity cover implies a large liquidity buffer of R3.4bn relative to the net cashflow of -R29m over the period H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to R1 934m +1% Cashflows from existing business NB Strain and Net FinRe Net Cashflow excl COVID-19 COVID-19 Impact* Net Cashflow after COVID-19 Life and Invest cashflow (Rm) *Net of additional financing -- 44 of 72 -- 45 Robust embedded value growth driven by positive operating variances and inforce growth, resilient new business margins to R38.1bn Life and Invest embedded value (Rbn) +10% Value of new business and margin VNB (Rm) Life: Annualised VNB margin (%) Life: Margin improvement vs. June 21: • COVID-19 provision unwind • Pricing and product initiatives • Focus on quality over quantity of new business • Expense controls June 2021 New business Expected unwind incl New Business Experience Variances Methodology and Assumption Changes Total before Economic Impact Experience Variances Methodology and Assumption Changes Components below the line December 2021 34.8bn 37.3bn 38.1bn Economic Non-economic 291 120 227 H1 2021 H2 2021 H1 2022 8.2% 5.70% 6.8% H1 2021 FY 2021 H1 2022 +20% Positive non- economic experience variances Annualised ROEV before economic impact +15% H1 2022 (Rm) 286 Lapses and surrenders Mortality and morbidity Premium and fee income Policy alterations Other Total -- 45 of 72 -- 46 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Robust performance with strong increase in new business growth and assets under management -- 46 of 72 -- 47 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Discovery Invest Normalised operating profit New business Assets under administration Lapse rates Shared value outcomes H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 2018 2019 2020 2021 2022 H1 H1 H1 H1 H1 +10% +15% -16% to R517m to R1 519m +19%to R128bn lower drawdowns 12% more years to retirement 7.5 in shared value benefits accrued and paid to clients R13bn Since the launch of shared value: -- 47 of 72 -- 48 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Difficult period, characterised by an increased loss ratio driven by adverse weather events combined with motor parts inflation dramatically exceeding CPI -- 48 of 72 -- 49 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Discovery Insure New business Gross written premium to R2 318m1 to R597m1 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 1 Personal lines figures only 2 CMT is in the building phase and the decrease in CMT profitability in 2021 and 2022 is due to the acquisition of TrueMotion and associated costs -3% +13% Market share in GWP Personal Lines only. Assumes 6% in GWP market growth since 2018 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 7% Vehicles insured +11% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to 292 0001 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 CMT Personal lines Normalised operating profit to R15m2 -86% -- 49 of 72 -- 50 51% 53% 55% 57% 59% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% Blue Bronze Silver Gold and diamond Improved quality of drivers but external factors affected claims Improved loss ratios with client duration Loss ratio by duration H1 2022 0% 25% 50% 75% 100% 0 1 2+ 0 20 40 60 80 100 Blue Bronze Silver Gold Diamond Better risks from gold and diamond drivers -48% Lower loss ratios than Blue Relative loss ratios by Vitality Drive status Retention of good drivers Lapse rates by Vitality status -73% Lower lapses compared to Blue clients H1 2022 loss ratio higher than 2021 Loss ratios H1 2018 – H1 2022 +3% High car parts inflation +1% Hailstorms +1% Fire claims +1% Power surge -2% Other -- 50 of 72 -- 51 Economic and environmental factors contributed to a higher loss ratio High inflation1 in the cost of car parts Resulting from rapidly increasing shipping costs Impact with value of car makers Car makers by value insured TOYOTA 13% MERCEDES- BENZ 11% VOLKSWAGEN 11% BMW 10% FORD 10% LAND ROVER 5% AUDI 5% HYUNDAI 5% NISSAN 3% MAZDA 3% KIA 3% PORSCHE 3% RENAULT 2% HONDA 2% SUZUKI 2% OTHER 14% Car parts inflation by car different car makers Average car parts inflation in 2020 16.90% 16.90% 14.10% 12.50% 10.40% -10% 0% 10% 20% Car brand A Car brand B Car brand C Car brand D Car brand E Car brand F Car brand G Car brand H Car brand I Car brand J 2020 2021 Average car parts inflation in 2021 13.2% 3.2% Jul-19 Oct-19 Jan-20 Apr-20 Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 Global container freight rate index from July 2019 to January 20222 10% - 15% 1 inflation based on initial costing 2 https://www.statista.com/statistics/1250636/global-container-freight-index/ High repair cost inflation, hailstorms and fire claims Reasons for variations in AvE claims Hailstorms Fire claims Power surge High motor repair cost inflation Total variation in actual vs expected claims Other Once-off Recurring 19% 11% 7% 43% 18% 4X X 500% increase in cost of car parts due to increase in shipping costs -- 51 of 72 -- 52 Vitality Health Vitality Car Vitality Life Vitality Invest -- 52 of 72 -- 53 Lives covered UK Composite Normalised operating profit Earned premiums New business GBP millions GBP millions GBP millions Vitality Health Vitality Car Vitality Life Vitality Invest Best-in-breed products across businesses and operating as a fully integrated composite business with a seamless One Vitality client journey to £438m to £54.2m +36% +7% +11% +7% to £77.2m to 1.48m lives H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 -- 53 of 72 -- 54 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Vitality Health Normalised operating profit Earned premiums Lives covered New business GBP millions GBP millions GBP millions H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to £274m to £41.5m +44% +7% +10% +15% to £34.5m to 764k lives -- 54 of 72 -- 55 Strong performance across all metrics driving strong profit growth Excellent performance of retention strategy 100 82 84 82 81 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Lapse rates 100 91 86 88 80 H1 2017 H1 2018 H1 2019 H1 2020 H1 2022 Per life per month expenses Further improvement in expense efficiencies High impact of pricing initiatives over time Focus on Renewal pricing and Lapse modelling New business pricing sophistication New business as a % of lives insured Lapses as a % of lives insured H1 2017 H1 2019 H1 2022 154k Lives added 68k Lives added 8% 9% 4.2% -- 55 of 72 -- 56 Strategically positioned to accommodate a catch-up in claims post- COVID-19 Authorisations have returned to pre-COVID-19 levels Widening access to care through digital pathways has improved efficiency of care delivery 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 Cardiac Musculoskeletal Oncology Psychiatry Total 0% 10% 20% 30% 40% 2015 2016 2017 2018 2019 2020 2021 Vitality GP Talking Therapies Physiotherapy 2015 2017 2019 2021 2015 2016 2017 2018 2019 2020 2021 Talking Therapies Total Claims 2020 2021 Primary care now accounts for over 40% of all claims, up from less than 10% in 2015 Physiotherapy volumes have increased, with digital pathways now accounting for ~60% of claims Talking Therapies has grown to represent over 80% of all mental health claims Digital Offline % of Claims on Primary care Volume of mental health claims Monthly authorisations per 1000 lives Hip replacement Knee replacement Before network After network Expansion of premier consultant network has improved claims cost efficiencies -10% -11% Over 100k virtual consultations in 2021 -- 56 of 72 -- 57 Vitality Life Normalised operating profit Earned premiums Lives covered New business H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to £164m +7% +6% to 686k lives GBP millions GBP millions GBP millions H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 to £17.6m +15% +3% to £27.1m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 -- 57 of 72 -- 58 0% 20% 40% 60% 80% 100% 120% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Expected Positive trend in lapse AvE continued Continued strong operating performance driven by excellent retention strategy Benefits from addressing 10 point plan now being witnessed Intervened against ‘high lapse’ brokers Restructured franchise channel Consolidated ops and service at Group level Enhanced retention capabilities Strengthened actuarial bases and set up COVID-19 provisions Entered into interest rate hedge Deferred Part VII transfer Changed Group legal entity structure Adapted elements of actuarial methodology Sourced liquidity funding in the UK Area Management actions 1 2 3 4 5 6 7 8 9 10 OPERATIONS CAPITAL LIQUIDITY 0.7 0.9 1.1 1.3 1.5 Hedge performed well in a volatile interest rate environment Improving swap rates have increased the intrinsic value of the swaption Swaption in the money -30 -20 -10 0 10 20 30 01-Jul-21 01-Aug-21 01-Sep-21 01-Oct-21 01-Nov-21 01-Dec-21 Liability P/L Net P/L Swap P/L GBP Millions -- 58 of 72 -- 59 USA HEALTH -- 59 of 72 -- 60 Strong underlying growth. Broadening our global impact through a health insurtech JV in Asia with AIA Vitality Health International Insurance Partner Markets USA HEALTH -- 60 of 72 -- 61 Vitality Group 1 All insurance partnerships excluding equity investments 2 Excludes services related to system implementation and other cost recoveries and rewards Revenue Operating result to $44.5m R667.5m Integrated API by insurance partners Insurance partners membership to $766m R11.5bn to $15.5m R234m to 2.7m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Insurance Partners Vitality USA H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 1 2 +26% +45% Gains from Foreign Exchange Contract taken out during COVID period -- 61 of 72 -- 62 Insurance Partner Markets -- 62 of 72 -- 63 - 20 40 60 80 100 120 2019 2020 2021 2022 2023 2024 2025 2026 $ million Revenue Expenses Margin 27% 67% New market Old market 9 46 157 Insurance Partner Markets Continued robust performance as the platform scales Margin emergence Insurance markets revenue & expenses Actual → Forecasted 60% * • H1 is based on actuals. H2 is based on forecast. • Forecast information is indicative only and has not been audited or reviewed” 38% Guaranteed revenue Strong intrinsic contract values KPIs Number of markets Penetration rates Engagement Integrated products API & Members 2016 2021 2017 2018 2019 2020 28 2017 2018 2019 2020 2021 Present value of existing contract revenues -- 63 of 72 -- 64 Shared-value health insurance approach Unique ecosystem Vitality Health International Broadening our global impact Vitality Health International USA HEALTH -- 64 of 72 -- 65 Extending the behavioural platform through a health insurtech JV in Asia with AIA Capital-light and technology-centric insurtech business Improves clients’ underlying performance & shares in the value created • Proprietary IP and native strength of digital assets and programs • 250 Discovery talent, including senior management • Global innovator in health insurance with success in both developed and emerging markets • 30 years of experience and execution track record • Providing initial capital • Leading pan-Asian health businesses, with a captive base of ~50m clients across 9 key geographies • Deep understanding and networks in Asia and a trusted brand with high recognition • 100+ years experience with execution track record and medical expertise 75% 25% equity stake, a series of IP and performance fees and a material relief from capital equity stake -- 65 of 72 -- 66 Offering a full suite of services to healthcare businesses Claims & Core Operations Value-based networks Medical cost optimisation Digital engagement Data and analytics Insurance Propositions Products Market segments Existing AIA health businesses Corporates Private and public providers Pharma/ Medtech DATA ANALYTICS & HEALTH INTELLIGENCE HEALTH INSURANCE TECHNOLOGY PRODUCT ARCHITECTURE VIRTUAL CARE AND PROVIDER NETWORKS CLAIMS & ADMINISTRATION DIGITAL HEALTH ECOSYSTEM CLAIMS ANALYSIS SEGMENTATION & PROFILING VALUE-BASED CARE PRIMARY CARE HOSPITAL CARE CRITICAL ILLNESS CARE DELIVERY NETWORKS Capabilities Private and public payors -- 66 of 72 -- 67 Year 0 Year 1 Year 2 Year 3 Year 4 Year 5 Claims reduction Significant value to be unlocked in an enormous market Amplify Health has already proven potential through a POC Potential to scale in rapidly-expanding digital healthcare space in Asia Insurance Market A| Medical Cost Optimisation (Fraud, Waste & Abuse) FWA Capability Development claims savings in 5-year period 2020 healthcare expenditure in markets where AIA operate Annual growth in Asia health expenditure (vs 5% in developed markets) AIA Markets Individual policies Group insurance scheme members (AIA only) Pharma/ Medtech Expenditure in 2019 1 1 Source: Marketresearch.com Digital Health Market size in 2020 Growing at ~40% year-on-year 2 2 Source: McKinsey Insights Insurer Dynamics| claims per annum GP clinics major hospitals Asia healthcare expenditure within the next 10 years in markets where AIA operate -- 67 of 72 -- 68 Ping An Health PAH’s operating results pre-tax to R1.1bn (DSY’s share is R277m) New business1 to R5.7bn Written premium1 to R20.4bn 1 100% of PAH Discovery’s operating result after tax to R140m H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Own Licence Reinsurance H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 Growth in Own Licence business H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 -- 68 of 72 -- 69 Exceptional calendar year growth, focused on sustainable growth reflected through high-quality business metrics -500 0 500 1,000 1,500 2,000 2,500 3,000 3,500 2017 2018 2019 2020 2021 Jan-June July-Dec Operating result grew 44% over CY2021 Calendar year growth PAH operating result pre-tax ZARm High quality metrics and balance sheet strength Absolute improvement since prior period in Combined Operating Ratio Figures shown for CY2021 1 Incudes reinsurance lives 2 Chinese Life Insurers Ranking Q3 2021 Profit ranking out of 80 insurers1 Market share2 PAH is one of the most profitable insurers in China Return on equity Solvency Ratio (as at 31 Dec 2021) Net profit margin (19% improvement since prior period) Net Asset Value (26% growth from prior period) Lapse rates Lives1 Dec-19 Jun-20 Dec-20 Jun-21 Dec-21 -3.1% -- 69 of 72 -- 70 2019 2020 2021 Distribution channels are being optimised to adapt to a maturing business model, balancing both scale and quality Historic business model prioritised scale to establish market position Beijing Hebe i Tianji n Jiangsu Shanghai (HQs) Zheijian g Sichuan Guangdong Shenzhen Hen an Hubei Liaoni ng Chongqi ng Shandong Fujian Hunan PAH licensed regions PAH unlicensed regions PAH licensed regions represent 58% of GDP1 Maturing business model leverages capabilities to create customers value Optimise distribution channels to own customers Selectively expand PAG collaboration to reach targeted customer segments Areas with an insurance license Control 100% of business Customer access Higher profitability Control expenses, commissions and pricing Opportunity identified Leverage insurance capabilities to generate revenue and profits Ability to manage risk Directly manage underwriting, pricing & risk management Continue branch expansion and grow own license business Change in Combined Operating Ratio -3.7% 1 Source: China statistical yearbook 2021 edition Reaching customers through new and diverse channels Dec-20 Dec-21 Group channel Others SuiShenYi Non-PAL Cross selling PAL individual channel 28% 44% New business split through own license channels Development of new channels Ping An Bank Holistic bank providing retail, corporate, and banking technology services to clients across China Ping An Puhui A leading technology- powered platform, providing access to financing for small and micro enterprises -- 70 of 72 -- 71 Three concurrent areas of focus Navigating COVID-19 Drive for growth Robust performance with capital and liquidity strength -- 71 of 72 -- UNAUDITED INTERIM RESULTS for the six months ended 31 December 2021 -- 72 of 72 --